Xenometrix AG Our vision is to provide high quality and efficient mutagenicity and cytotoxicity test systems. We are a company specialized in the production, distribution and service of mutagenicity test systems, namely Ames II, Ames MPF 98/100, Ames MPF 1535, Ames MPF 1537, Ames MPF E.coli WP2 uvrA, Ames MPF E.coli WP2 pkM101. The tests come as a complete kit, are quality controlled and are run in a liquid format on 384 well plates. The assay system is a version of the Ames fluctuation test cited in the OECD / FDA guidelines (except Ames II). Our company also produces single and multiple endpoint cytotoxicity assays covering a wide range of mechanisms and read-outs. The test kits are typically used in the early screening phase to determine cytotoxicity endpoints in eukaryotic cells. Our company is the only company offering 4-endpoint cytotoxicity assays. Xenometrix Testkits are produced for the use in molecular pharmacology, early stages of drug discovery, screening of chemical, cosmetic, alimentary or agrochemical compounds and for testing environmental water, soil, air or effluents.